JOSE CASTELLOTE
Newtown,USA
Summary
Jose Castellote is a seasoned global healthcare commercial leader with extensive experience driving growth, shaping strategies, and leading diverse teams across multiple regions and disciplines in the healthcare industry.
His expertise spans market access, business development, marketing strategy, and commercial operations, with a proven record of launching products and expanding business footprints in emerging and established markets.
Customer-oriented General Manager with 20+ years of experience focused on increasing revenues and expanding margin. Adaptive and deadline-oriented consistently executes and completes multiple projects in high-stress environments.
Meticulous leader and strategic planner with comprehensive managerial acumen, offering vision and motivational acumen.
Overview
27
27
years of professional experience
1
1
Certification
Work History
General Manager, Puerto Rico
Johnson & Johnson Innovative Medicine
10.2023 - Current
- Directed full P&L ownership for J&J Innovative Medicine portfolio (~$300m, ~70 employees), driving strategic prioritization across Oncology, Hematology, Immunology, Cardiovascular & Metabolic, Infectious Diseases, and Neuroscience.
- Accelerated market leadership by aligning cross-functional teams and executing high-impact initiatives, resulting in record-breaking performance with ~30% volume growth for key assets and market dominance in Oncology becoming the #1 Oncology company in Puerto Rico.
National Sales Director, SPRAVATO
Johnson & Johnson Innovative Medicine
12.2021 - 09.2023
- Led national sales strategy for SPRAVATO (Esketamine), translating brand vision into actionable regional and customer plans. Managed a team of over 250 employees delivering nearly $600 m sales in 2023.
- Ideated, aligned and executed on a new Go to Market model for Spravato including customer segmentation and targeting, field force deployment as well as a shift in the compensation and incentive strategy.
Global Commercial Leader, Neuropsychiatry
Johnson & Johnson Innovative Medicine
12.2019 - 11.2021
- Developed global commercial strategy for Neuropsychiatry portfolio in partnership with R&D and regional teams.
- Advanced launch readiness for key Phase 3 assets including Invega TREVICTA, Seltorexant, and Aticaprant through integrated planning and stakeholder engagement.
Senior Director, Emerging Market Access
Johnson & Johnson Innovative Medicine
04.2018 - 12.2019
- Championed market access advancement in Emerging Markets by co-leading the Emerging Markets Forum and engaging senior leadership.
- Built global COE capabilities in access strategy, enabling lifecycle planning and value proposition development for alternative payers and disease management programs.
Country Head, Gulf Countries & Head of Commercial Operations GCC
Johnson & Johnson Innovative Medicine
02.2016 - 04.2018
- Oversaw commercial operations across Gulf countries, managing $100M business and leading over 50 FTEs across Sales, Market Access, and Distribution.
- Strengthened operational capabilities and financial planning through stakeholder alignment and process optimization.
Business Unit Director, Neuroscience – GCC
Janssen, Pharmaceutical Companies of Johnson & Johnson
03.2014 - 02.2016
- Directed Neuroscience business unit across GCC, launching Invega Sustenna and driving strategic growth across six countries.
- Unified sales, marketing, market access, and medical affairs to achieve business targets and elevate portfolio impact.
Professional Marketing Manager
Johnson & Johnson Consumer MENAP
04.2012 - 02.2014
- Led professional marketing strategy across MENAP region for Baby, CHC, and Adult portfolios, enhancing HCP engagement and brand equity.
- Activated J&J brands through strategic partnerships and execution excellence across 12 countries and 6,000+ HCPs.
Country Manager, Nigeria
AstraZeneca
05.2010 - 03.2012
- Established AstraZeneca’s commercial operations in Nigeria, building legal entity, distributor network, and supply chain infrastructure.
Sales Force Effectiveness Projects Manager, Emerging Markets
AstraZeneca Global Sales & Marketing
01.2009 - 04.2010
- Delivered SFE excellence in Emerging Markets as SME, optimizing segmentation, targeting, deployment, and incentive schemes.
Go to Market Consultant
Reckitt Benckiser
06.2006 - 12.2008
- Redefined Go-To-Market strategy for Reckitt Benckiser in Europe, optimizing field force deployment and key account structures.
Sales Force Effectiveness Consultant
IMS HEALTH (now IQVIA)
02.2005 - 05.2006
- Led SFE projects across EMEA, specializing in segmentation, targeting, territory alignment, and route planning for primary and specialty care.
Key Account Manager
IMS HEALTH (now IQVIA)
12.2001 - 01.2005
- Managed strategic accounts, delivering data-driven solutions and client engagement across healthcare portfolios.
Intern, Market Analyst
The Nielsen Company
01.1999 - 11.2001
- Supported market analysis, contributing to consumer insights and data interpretation for strategic decision-making.
Education
Bachelor’s degree - marketing, Economics and Business
Universidad Anahuac del Norte
01.2000
Skills
- Market access strategy
- Business growth strategies
- Strategic organizational development
- Targeted marketing strategies
- Stakeholder engagement strategy
- Effective business model design
- Value-driven pricing strategy
- Payer relationship management
- Proficient in commercial execution
Accomplishments
- Strategic Transformations and Portfolio Optimizations: Jose has led strategic transformations and portfolio optimizations in Oncology, Hematology, Immunology, and Neurosciences, achieving record-breaking performance and positioning Johnson & Johnson as a market leader in Puerto Rico.
- Professional Experience in the US: Jose has held several key positions in the US, including Senior Director of Emerging Market Access, Global Commercial Leader for Neuropsychiatry, and National Sales Director for SPRAVATO at Johnson & Johnson Innovative Medicine. These roles involved developing global commercial strategies, advancing launch readiness for key assets, and leading national sales strategies to exceed financial targets and expand market penetration.
- General Manager, Puerto Rico: Currently, Jose is the General Manager for Johnson & Johnson Innovative Medicine in Puerto Rico, where he directs full P&L ownership for the portfolio, driving strategic prioritization across multiple therapeutic areas and achieving category dominance in Oncology. Notably, Puerto Rico reports into the US Neuroscience business, further aligning with Jose's extensive experience in the US market.
Certification
- Talent Acceleration Program – Johnson & Johnson EMEA (2015–2016): Selected for high-potential leadership development, focused on strategic thinking, cross-functional collaboration, and global business acumen.
- Health Economics Academy – EMEA (2015–2017): Advanced training in health economics, market access, and payer strategy to support value-based healthcare decision-making.
Career Highlights
Strategic Transformations and Portfolio Optimizations: Jose has led strategic transformations and portfolio optimizations in Oncology, Hematology, Immunology, and Neurosciences, achieving record-breaking performance and positioning Johnson & Johnson as a market leader in Puerto Rico.
Languages
English
Native or Bilingual
Spanish
Native or Bilingual
French
Limited Working
Timeline
General Manager, Puerto Rico
Johnson & Johnson Innovative Medicine
10.2023 - Current
National Sales Director, SPRAVATO
Johnson & Johnson Innovative Medicine
12.2021 - 09.2023
Global Commercial Leader, Neuropsychiatry
Johnson & Johnson Innovative Medicine
12.2019 - 11.2021
Senior Director, Emerging Market Access
Johnson & Johnson Innovative Medicine
04.2018 - 12.2019
Country Head, Gulf Countries & Head of Commercial Operations GCC
Johnson & Johnson Innovative Medicine
02.2016 - 04.2018
Business Unit Director, Neuroscience – GCC
Janssen, Pharmaceutical Companies of Johnson & Johnson
03.2014 - 02.2016
Professional Marketing Manager
Johnson & Johnson Consumer MENAP
04.2012 - 02.2014
Country Manager, Nigeria
AstraZeneca
05.2010 - 03.2012
Sales Force Effectiveness Projects Manager, Emerging Markets
AstraZeneca Global Sales & Marketing
01.2009 - 04.2010
Go to Market Consultant
Reckitt Benckiser
06.2006 - 12.2008
Sales Force Effectiveness Consultant
IMS HEALTH (now IQVIA)
02.2005 - 05.2006
Key Account Manager
IMS HEALTH (now IQVIA)
12.2001 - 01.2005
Intern, Market Analyst
The Nielsen Company
01.1999 - 11.2001
Bachelor’s degree - marketing, Economics and Business
Universidad Anahuac del Norte
Similar Profiles
ANIS TRIKIANIS TRIKI
Medical Science Liaison – Urogenital Tumors at Johnson & Johnson Innovative MedicineMedical Science Liaison – Urogenital Tumors at Johnson & Johnson Innovative Medicine
Laura G. Bermudez CottoLaura G. Bermudez Cotto
Manufacturing Process Specialist at Johnson & Johnson Innovative MedicineManufacturing Process Specialist at Johnson & Johnson Innovative Medicine
Giacomo BecheriGiacomo Becheri
Sr. Manager Validation, MSIT at Johnson & Johnson Innovative MedicineSr. Manager Validation, MSIT at Johnson & Johnson Innovative Medicine
Ruchin KansalRuchin Kansal
Visiting Professor of the Practice of Leadership at BROWN UNIVERSITYVisiting Professor of the Practice of Leadership at BROWN UNIVERSITY
Pamela BouchardPamela Bouchard
PRESIDENT/OWNER at Pamela Bouchard LLCPRESIDENT/OWNER at Pamela Bouchard LLC